{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:57:30Z","timestamp":1773982650901,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The rate of decay of antibody concentration following serogroup C meningococcal (MenC) polysaccharide-protein conjugate vaccination varies between individuals. This depends partly on vaccination age but may be influenced by human genetics. We studied 721 single nucleotide polymorphisms (SNPs) across 131 candidate genes in a first cohort of 905 Caucasians (11 to 21 years old; mean time after vaccination, 4.9 years) and 30 SNPs across 17 genes in a replication study using 155 children, aged 6 to 12 years (mean time after vaccination, 6.7 years), and 196 infants (1 year old; mean time after vaccination, 8 months). Individuals were classified as responders or nonresponders for total MenC IgG concentration and MenC serum bactericidal antibody (SBA) measurements. Associated genes were examined further for quantitative outcome measures. Fifty-nine SNPs in 37 genes were associated with IgG persistence (adjusted for age at measurement), and 56 SNPs in 36 genes were associated with SBA persistence (adjusted for age at measurement and vaccine used). Three SNPs each within the Toll-like receptor 3 (TLR3) (rs3775291, rs3775292, and rs5743312) and CD44 (rs11033013, rs353644, and rs996076) genes were associated with IgG (adjusted for age at measurement) or SBA (adjusted for age at measurement and vaccine used) persistence in the initial genetic study (<jats:italic>P<\/jats:italic>, 0.02 to 0.04). Single SNPs within the TLR3 (rs7657186) (<jats:italic>P<\/jats:italic>= 0.004 [unadjusted]) and CD44 (rs12419062) (<jats:italic>P<\/jats:italic>= 0.01 [unadjusted]) genes were associated with IgG persistence in the replication study. These results suggest that genetic polymorphisms in the TLR3 and CD44 genes are associated with the persistence of the immune response to MenC vaccines 1 to 6 years after vaccination.<\/jats:p>","DOI":"10.1128\/cvi.05379-11","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T02:17:33Z","timestamp":1325125053000},"page":"295-303","source":"Crossref","is-referenced-by-count":18,"title":["Single Nucleotide Polymorphisms in the Toll-Like Receptor 3 and CD44 Genes Are Associated with Persistence of Vaccine-Induced Immunity to the Serogroup C Meningococcal Conjugate Vaccine"],"prefix":"10.1128","volume":"19","author":[{"given":"Catrin E.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branwen J.","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten P.","family":"Perrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Claire","family":"Hoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Brocklebank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2011,12,28]]},"reference":[{"key":"key20180919073556_B1","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI111909","article-title":"Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria","volume":"75","author":"Ambrosino","year":"1985","journal-title":"J. Clin. Invest."},{"key":"key20180919073556_B2","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073556_B3","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"key20180919073556_B4","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073556_B5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in Toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073556_B6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1083\/jcb.200507128","article-title":"Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures","volume":"173","author":"Doulet","year":"2006","journal-title":"J. Cell Biol."},{"key":"key20180919073556_B7","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"key20180919073556_B8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073556_B9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"key20180919073556_B10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"key20180919073556_B11","doi-asserted-by":"crossref","first-page":"e1898","DOI":"10.1371\/journal.pone.0001898","article-title":"Host genetic factors and vaccine-induced immunity to hepatitis B virus infection","volume":"3","author":"Hennig","year":"2008","journal-title":"PLoS One"},{"key":"key20180919073556_B12","first-page":"201","article-title":"Genetic variation in the response to vaccination","volume":"10","author":"Kimman","year":"2007","journal-title":"Community Genet."},{"key":"key20180919073556_B13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/656236","article-title":"Association between single-nucleotide polymorphisms in Mal\/TIRAP and interleukin-10 genes and susceptibility to invasive Haemophilus influenzae serotype b infection in immunized children","volume":"51","author":"Ladhani","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073556_B14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11568-010-9134-1","article-title":"Genetic determinants of immune-response to a polysaccharide vaccine for typhoid","volume":"3","author":"Majumder","year":"2009","journal-title":"Hugo J."},{"key":"key20180919073556_B15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun."},{"key":"key20180919073556_B16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00439-009-0763-1","article-title":"Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes","volume":"127","author":"Ovsyannikova","year":"2010","journal-title":"Hum. Genet."},{"key":"key20180919073556_B17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(79)90584-1","article-title":"Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysaccharides","volume":"i","author":"Pandey","year":"1979","journal-title":"Lancet"},{"key":"key20180919073556_B18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"key20180919073556_B19","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073556_B20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"key20180919073556_B21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"key20180919073556_B22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"key20180919073556_B23","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1371\/journal.pone.0012273","article-title":"Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis","volume":"5","author":"Ryckman","year":"2010","journal-title":"PLoS One"},{"key":"key20180919073556_B24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","article-title":"Multiplicity in randomised trials","volume":"365","author":"Schulz","year":"2005","journal-title":"I. Endpoints and treatments. Lancet"},{"key":"key20180919073556_B25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00439-008-0511-y","article-title":"Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics","volume":"123","author":"Sirugo","year":"2008","journal-title":"Hum. Genet."},{"key":"key20180919073556_B26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"key20180919073556_B27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"key":"key20180919073556_B28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","article-title":"Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines","volume":"168","author":"Zarember","year":"2002","journal-title":"J. Immunol."},{"key":"key20180919073556_B29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect. Immun."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.05379-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:47:03Z","timestamp":1627591623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05379-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,28]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,2,27]]},"published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1128\/CVI.05379-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05379-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,28]]}}}